Alienys Izquierdo

CAPSID PROTEINS: EVIDENCES ABOUT THE PROTECTIVE ROLE OF CELL-MEDIATED IMMUNITY AGAINST DENGUE

Gil González Lázaro, Alienys Izquierdo, Lazo Vázquez Laura, Valdés Prado Iris +11 more

20148th Cuban Congress on Microbiology and Parasitology, 5th National Congress on Tropical Medicine and 5th International Symposium on HIV/aids infection in Cuba0 citations

OpenAlex

Alienys Izquierdo

Most-cited papers

Dengue infection

Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders

Asymptomatic Dengue Infection in a Cuban Population Confirms the Protective Role of the RR Variant of the FcγRIIa Polymorphism

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

Primary and Secondary Infections ofMacaca fascicularisMonkeys with Asian and American Genotypes of Dengue Virus 2

The protein DIIIC‐2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV‐2

A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

Capsid protein: Evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys

Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys

Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice

Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design

Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2

A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine

A dose-response study in mice of the vaccine preparation containing the diiic-2 protein aggregated with the oligodeoxinucleotide 39m

Virus-like particles as nanovaccine candidates

Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response

RECOMBINANT DENGUE 2 VIRUS NS3 PROTEIN CONSERVES STRUCTURAL ANTIGENIC AND IMMUNOLOGICAL PROPERTIES RELEVANT FOR DENGUE VACCINE DESIGN

Esquemas de inmunización complementaria basados en la combinación de una formulación tetravalente de proteínas recombinantes y virus vivos atenuados: estrategia vacunal contra el dengue

Esquemas de inmunización complementaria basados en la combinación de una formulación tetravalente de proteínas recombinantes y virus vivos atenuados: estrategia vacunal contra el dengue

Nucleocapsid-like particles, an alternative and safe vaccine strategy against Dengue virus based on the induction of cell-mediated alone adaptive immune responses

Demostración de la capacidad protectora de candidatos vacunales contra el virus del dengue basados en la proteína de la cápsida y el oligodesoxinucleótido 39M

Capacidad protectora de candidatos vacunales contra el virus dengue serotipo 2 basados en la proteína de la cápsida y el oligodesoxinucleótido 39M

Protective capacity of vaccine candidates against dengue virus type 2 based on the capsid protein and the oligodeoxynucleotide 39M

CAPSID PROTEINS: EVIDENCES ABOUT THE PROTECTIVE ROLE OF CELL-MEDIATED IMMUNITY AGAINST DENGUE

EVALUATION IN MICE OF THE IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A TETRAVALENT SUBUNIT VACCINE CANDIDATE AGAINST DENGUE VIRUS

TETRA DIIIC: A NOVEL VACCINE CANDIDATE AGAINST DENGUE

Evaluación de la especificidad de serotipo de las proteínas recombinantes DominioIII-Cápside de los virus del dengue

Prueba de concepto en primates no humanos de estrategia de inmunización contra dengue con virus del serotipo 2 y re-estimulación con proteínas recombinantes que portan el dominio III de la proteína de la envoltura viral

IgG Subclass and the FcG Receptor Iia Polymorphism Associate to Dengue Fever, Dengue Hemorrhagic Fever and Asymptomatic Dengue Infection in Cuba